BONOMINI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 13.546
EU - Europa 7.599
AS - Asia 7.515
Continente sconosciuto - Info sul continente non disponibili 1.474
SA - Sud America 925
AF - Africa 119
OC - Oceania 19
Totale 31.197
Nazione #
US - Stati Uniti d'America 13.162
SG - Singapore 2.846
CN - Cina 2.109
IT - Italia 1.411
UA - Ucraina 1.144
IE - Irlanda 1.107
TR - Turchia 863
RU - Federazione Russa 843
SE - Svezia 742
GB - Regno Unito 727
BR - Brasile 701
VN - Vietnam 653
DE - Germania 543
FR - Francia 470
IN - India 360
FI - Finlandia 266
CA - Canada 210
BD - Bangladesh 182
HK - Hong Kong 153
PL - Polonia 70
AR - Argentina 68
MX - Messico 55
JP - Giappone 54
NL - Olanda 50
ZA - Sudafrica 50
AT - Austria 40
CZ - Repubblica Ceca 39
EC - Ecuador 39
IQ - Iraq 38
CO - Colombia 36
KR - Corea 36
ES - Italia 35
ID - Indonesia 34
BE - Belgio 27
CL - Cile 26
JM - Giamaica 19
PY - Paraguay 19
SA - Arabia Saudita 19
VE - Venezuela 19
CR - Costa Rica 18
IL - Israele 18
AU - Australia 17
EG - Egitto 16
UZ - Uzbekistan 16
HN - Honduras 15
IR - Iran 15
LT - Lituania 15
EU - Europa 14
MY - Malesia 14
PK - Pakistan 13
EE - Estonia 12
MA - Marocco 12
TT - Trinidad e Tobago 12
GT - Guatemala 11
JO - Giordania 11
NP - Nepal 11
CH - Svizzera 10
AE - Emirati Arabi Uniti 9
BB - Barbados 8
UY - Uruguay 8
AL - Albania 7
DO - Repubblica Dominicana 7
DZ - Algeria 7
LB - Libano 7
NI - Nicaragua 7
PH - Filippine 7
BO - Bolivia 6
KE - Kenya 6
PS - Palestinian Territory 6
SN - Senegal 6
TH - Thailandia 6
TW - Taiwan 6
AZ - Azerbaigian 5
SV - El Salvador 5
BG - Bulgaria 4
BY - Bielorussia 4
CG - Congo 4
DK - Danimarca 4
ET - Etiopia 4
KZ - Kazakistan 4
NO - Norvegia 4
OM - Oman 4
PT - Portogallo 4
TN - Tunisia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
GR - Grecia 3
KG - Kirghizistan 3
LV - Lettonia 3
MN - Mongolia 3
PA - Panama 3
PE - Perù 3
QA - Qatar 3
RO - Romania 3
RS - Serbia 3
AW - Aruba 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DM - Dominica 2
Totale 29.712
Città #
Singapore 1.927
San Jose 1.590
Jacksonville 1.280
Dublin 1.094
Chandler 1.052
Ashburn 1.047
Council Bluffs 689
Dallas 584
Princeton 517
Beijing 467
Southend 450
Izmir 418
Los Angeles 386
Houston 376
Nanjing 356
New York 281
Wilmington 277
Ho Chi Minh City 232
Santa Clara 230
Dearborn 219
Cambridge 209
Chieti 185
Buffalo 176
Tongling 162
Altamura 145
Nanchang 143
Hong Kong 142
Ann Arbor 130
The Dalles 126
Hanoi 119
Woodbridge 102
Phoenix 98
Munich 97
Moscow 91
Orem 81
Boardman 78
Shenyang 78
São Paulo 76
San Francisco 75
Rome 73
Pescara 72
Hebei 68
Brooklyn 64
Denver 62
Washington 62
Atlanta 60
Hefei 57
Chicago 55
Dong Ket 55
Redondo Beach 55
Tianjin 55
Jiaxing 54
Kunming 54
Milan 54
Montreal 54
Warsaw 51
Tokyo 48
Columbus 46
London 42
Toronto 42
Silver Spring 39
Nuremberg 38
Helsinki 35
Jinan 35
Johannesburg 33
Norwalk 32
Boston 31
Changsha 31
Seattle 31
Brno 30
Chennai 30
Da Nang 30
Hangzhou 30
Naples 29
Seoul 29
Vittuone 29
Ningbo 28
Kimball 27
Haiphong 26
Stockholm 26
Brussels 25
Frankfurt am Main 25
Ottawa 24
Zhengzhou 24
Augusta 23
Grevenbroich 23
Poplar 23
Bari 22
Amsterdam 21
Vienna 21
Leawood 20
Turku 20
Bologna 19
Shanghai 19
Düsseldorf 17
Kocaeli 17
Kyle 17
Manchester 17
San Mateo 17
Brasília 16
Totale 17.997
Nome #
Treatment options for anemia in kidney transplant patients: a review 1.157
[Erythrocyte abnormalities and their possible role in cardiovascular complications of uremia] 464
Therapy of glucocorticoid induced osteoporosis 281
Quali soluzioni future per la dialisi peritoneale? 248
Plasma protein carbonylation in chronic uremia 207
Epatotossicità acuta da amiodarone endovena in una paziente in emodialisi 207
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 204
Calcium Sensing Receptor Expression in Ovine Amniotic Fluid Mesenchymal Stem Cells and the Potential Role of R-568 during Osteogenic Differentiation 200
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 193
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 190
Prognostic value of morphologic and morphometric analyses in IgA nephropathy biopsies 187
Calcimimetic R-568 vasodilatory effect effect on mesenteric vascular beds from normotensive (WKY) and spontaneously hypertensive (SHR) rats. Potential involvement of vascular smooth muscle cells (vSMCs) 184
Proteomic investigations on the effect of different membrane materials on blood protein adsorption during haemodialysis 183
Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane 179
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cells 179
Calcimimetic R-568 and its enantiomer s-568 increase nitric oxide release in human endothelial cells 177
Beta2-microglobulin causes abnormal phosphatidylserine exposure in human red blood cells. 175
Nefropatie tubulo-interstiziali iatrogene: patogenesi e quadro clinico 171
Adsorption and carbonylation of plasma proteins by dialyser membrane material: in vitro and in vivo proteomics investigations 170
Emodiafiltrazione (HDF) con polisulfone (PSF) e neuropatia periferica: una valida alternativa al trattamento emodialitico tradizionale RDT) 169
Calcium Sensing Receptor activation by calcimimetic R-568 in human amniotic fluid mesenchymal stem cells: Correlation with osteogenic differentiation. 168
Angiodysplasia of the small bowel: a possible cause of anemia even in mild chronic renal failure 167
Proteomic analysis of protein adsorption capacity of different haemodialysis membranes 167
A new polymethylmethacrylate membrane for hemodialysis 164
L-carnitine inhibits a subset of platelet activation responses in chronic uraemia 163
Proteomics characterization of protein adsorption onto hemodialysis membranes 162
Elettrofisiologia del sistema nervoso centrale e periferico in pazienti in trattamento sostitutivo: effetti della RDT e della CAPD 161
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 160
Proteomic Investigations into Hemodialysis Therapy 160
Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis 158
Severa neutropenia durante trattamento con amoxicillina/acido clavulanico in un paziente in trattamento emodialitico regolare [Severe neutropenia during treatment with amoxicillin/clavulanic acid in a patient on regular hemodialysis treatment] 157
L-Carnitine is an osmotic agent suitable for peritoneal dialysis 157
Alterazioni del trasporto di Na+ e Ca++ in sinaptosomi di encefalo di ratto uremico: vi è correlazione con la trasmissione sinaptica? 156
Biocompatibility of DIAPES 156
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 156
Examining hemodialyzer membrane performance using proteomic technologies 152
In vitro microbiology studies on a new peritoneal dialysis connector 151
Valutazione dell'utilità del test al Captopril nella diagnostica dell'ipertensione renovascolare (IRV) 151
Effect of erythropoietin on primed leucocyte expression profile. 151
Current opinion on usage of L-carnitine in end-stage renal disease patients on peritoneal dialysis 151
Carnitine in metabolic disease: potential for pharmacological intervention 147
Urinary Peptidomic Biomarkers in Kidney Diseases 147
Nephrotoxicity induced by chemotherapy [Nefrotossicita' da chemioterapici] 146
Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations 146
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitine 145
Blood cell proteomics in chronic kidney disease 144
Nitric oxide synthetic pathway and cGMP levels are altered in red blood cells from end-stage renal disease patients 143
Thyroid function and plasma selenium in chronic uremic patients onhemodialysis treatment 142
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. 139
Alterazioni ematologiche nelle malattie renali e alterazioni renali in corso di malattie ematologiche 138
Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter 138
Update sull'impiego della proteomica in emodialisi 138
Efficacy of sodium thiosulphate in a case of calciphylaxis in a chronic nephropathic ninety-year-old patient on conservative therapy 138
Emodiafiltrazione (HDF) con membrane in polisulfone (PSF) ed eritropoietina ricombinante umana (r-HuEPO): si puo' fare di meglio? 137
Defining the potential antidepressant mode of action of acetyl-l-carnitine. 137
Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients 137
Rationale and design of PURE, a randomized controlled trial to evaluate Peritoneal Ultrafiltration with PolyCoreTM in Refractory Congestive Heart Failure 136
Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach 136
Platelet activation markers in patients with nephrotic syndrome: A comparative study of different platelet function tests 136
Thyroid function and selenium supplementation in dialytic patients affected by chronic renal failure 136
Terapia sostitutiva artificiale della malattia renale cronica 136
Carnitine palmitoyltransferase as a potential target for treating diabetes: is inhibition or activation preferable? 135
Increased erythrocyte phosphatidylserine exposure in chronic renal failure 135
On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria.] 134
A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient 133
Metabolic Syndrome in Survivors from the 2009 Earthquake in Italy 133
Extra-hepatic manifestations associated with Hepatitis and virus infection 133
L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis 133
Effects of L-carnitine administration on erythrocyte survival in haemodialysis patients 132
Dislipidemia e progressione della insufficienza renale cronica 131
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 131
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy 131
Calcimimetic R-568 and its enantiomer induce a rapid, reversible, and only partially endothelium-mediated vasodilation in perfused mesenteric arteries from normotensive and spontaneously hypertensive rats 130
Removal of uremic plasma factors using different dialysis modalities 129
Emodiafiltrazione con polisulfone: effetti elettrofisiologici sulla neuropatia uremica 129
Recovery time after hemodialysis is inversely associated with the ultrafiltration rate. 129
Proteomic Characterization of a New asymmetric Cellulose Triacetate Membrane for Hemodialysis 128
A rare case of acute tubular necrosis tenofovir alafenamide-related 128
Clinical and Economic Impact of Early Diagnosis of Chronic Kidney Disease in General Practice: The Endorse Study 127
Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure 127
Uremic toxicity and anemia 125
Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes 125
Proteomic analysis of protein adsorption onto haemodialysis membranes 125
Formalin-fixed paraffin-embedded renal biopsy tissues: an underexploited biospecimen resource for gene expression profiling in IgA nephropathy 125
Effetto ipolipemizzante della simvastatina nei pazienti in CAPD con ipercolesterolemia 124
Terapia ipolipemizzante nella insufficienza renale cronica 124
Use of oral hypoglycemic agents in patients with chronic kidney failure 124
Endoscopy as a tool for diagnosing and treating gastrointestinal angiodysplasia in haemodialysis patients 124
Effetto protettivo dei Ca++-antagonisti (CCB) sulla nefrotossicità da ciclosporina (CyA) 123
Miglioramento dell'attivita' elettrica cerebrale in pazienti uremici in trattamento emodialitico (RDT) dopo eritropoietina umana ricombinante (r-HuEPO) 123
Wireless capsule endoscopy in the diagnostic of small intestine angiodysplasia in chronic uremic patient 123
Alterazioni morfo-funzionali dell'apparato cardio-vascolare nei pazienti con malattia renale policistica autosomica dominante 123
Selenium in uremia 122
New treatment approaches for the anemia of CKD 121
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint 121
Treatment of cutaneous calciphylaxis with sodium thiosulfate: two case reports and a review of the literature 121
L-carnitine in uremic anemia 121
A moderate carnitine deficiency exacerbates isoproterenol-induced myocardial injury in rats 121
Hemodynamic-guided therapy in essential hypertension: a new pathophysiological approach 120
ACHIEVEMENT OF NKF/K-DOQI RECOMMENDED TARGET VALUES FOR BONE AND MINERAL METABOLISM IN INCIDENT HEMODIALYSIS PATIENTS: RESULTS OF THE FARO-2 COHORT 120
Totale 16.178
Categoria #
all - tutte 124.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.023 0 0 0 205 79 22 25 74 102 42 145 329
2022/20233.174 339 382 147 318 283 617 236 225 429 29 94 75
2023/20241.768 110 44 114 55 111 608 384 75 14 35 24 194
2024/20254.068 241 604 465 186 92 126 113 233 593 178 438 799
2025/202610.021 790 377 869 1.058 780 515 1.427 565 915 823 1.599 303
2026/20271.832 169 446 467 750 0 0 0 0 0 0 0 0
Totale 31.197